The 2026 Nobel Prize in Chemistry goes to Henri B. Kagan, professor emeritus at Université Paris-Sud, and Kenso Soai, professor emeritus at Tokyo University of Science, for complementary breakthroughs explaining how homochirality emerges. Kagan won for discovering nonlinear effects in asymmetric organic synthesis in 1986; Soai for developing autocatalytic asymmetric synthesis, culminating in the 2003 Soai reaction that generated chirality from achiral conditions for the first time outside nature.

The Nobel committee framed the award simply: the 2026 prize "is about making chemistry choose a mirror image." The two laureates' work, the committee said, answered a question that has stood for more than a century.

Their combined efforts "have provided a solution to a chemical mystery that is over a century old," said Heiner Linke, PhD, chair of the Nobel Committee for Chemistry. "The chemical reactions they have developed are spectacular."

Why homochirality matters to process chemists

Chiral molecules exist as non-identical mirror images with distinct biological properties. Life is homochiral: organisms build proteins exclusively from left-handed amino acids and sugars that are right-handed. Reactions that form chiral products typically yield equal mixtures of both enantiomers — a serious problem for pharmaceutical development, where only one mirror image of a drug molecule may be therapeutic and the other inert or harmful.

"Many molecules occur in two different versions, like my hands. They are one another's mirror image. They look alike, but they're not identical," Linke said.

Peter Somfai, PhD, professor of organic chemistry at Lund University and a Nobel committee member, told interviewers that how homochirality emerges is "probably the most fundamental question in life." Scientists have long debated how it arose billions of years ago. "Now we mimicked it in a lab today, not the way it happened four billion years ago, it's important to stress, but we have for the first time mimicked it," he said.

What did Kagan measure in 1986?

Before Kagan, chemists working on asymmetric reactions — a lineage running from Louis Pasteur's mid-19th-century tartaric acid studies to Willy Marckwald's first successful asymmetric reaction in the early 1900s, plus theoretical work by Bristol physicist Charles Frank, PhD — assumed that the enantiomeric composition of the product tracked linearly with that of the catalyst. Mixing left- and right-handed catalysts, the consensus held, should dilute product chirality proportionally.

Kagan tested that assumption directly. He ran reactions with different combinations of catalyst enantiomers and found the relationship was not linear: the left-right catalyst form drove the reaction differently than the right-right or left-left forms. That divergence — a nonlinear effect — offered a route to amplify formation of one enantiomer beyond what catalyst purity alone would predict. In 1986 he published descriptions of at least three asymmetric reactions displaying the effect.

The practical consequence for synthesis planning is significant: catalyst enantiopurity, a major cost driver in manufacturing, no longer maps one-to-one onto product purity.

How did Soai close the loop?

Soai built on Kagan's finding. While studying an asymmetric reaction with a nonlinear effect, he noticed structural similarities between the reaction's catalyst and its products — suggesting a catalyst could form itself autocatalytically. After screening different molecules, he published a 1995 paper describing a chiral substance that created copies of itself, though not at full enantiomeric purity.

Eight years later, in 2003, he presented the reaction now named after him. The Soai reaction produces an excess of one enantiomer that then catalyzes formation of more of itself, and it yields only one of the two possible mirror images. It was the first demonstration of chirality emerging from achiral or racemic starting conditions outside nature. Somfai called it "probably the coolest experiment in organic chemistry."

Soai learned of the award while shopping near his home in Hiroshima, Japan. "There are many excellent researchers in this field, so I'm very especially glad to receive this prize" and "to share the prize with Professor Henri Kagan, such a famous organic chemist," he told reporters.

From basic chemistry to manufacturing tools

Though the prize honors fundamental research, the committee tied it directly to industrial practice. Many active drug molecules are chiral, and selective preparation methods determine both safety and yield. "We need methods to selectively prepare them, and in developing such methods, the findings of this year's Nobel laureates are important. They provided powerful tools for this," Somfai said.

The discoveries have supported chemists designing manufacturing-scale reactions for drugs, flavors, scents and other materials. For R&D groups weighing catalyst costs against enantiomeric purity targets, the laureates' work remains the mechanistic foundation under modern asymmetric synthesis — and the committee's citation signals that autocatalytic amplification of chirality, demonstrated once in a single reaction class in 2003, may still have broader territory to claim.